PTCT
PTC Therapeutics Inc
62.30$
-0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -201.0% | – | – | – | -106.7% | – | – | – | – | – | |
| – | +30.1% | -31.4% | -87.3% | -7.6% | +4.3% | +6.8% | +5.0% | +46.5% | +16.1% | +19.5% | +3.0% | – | |
| – | -38.7% | +11.3% | +4.7% | +2.7% | -12.7% | +4.8% | +2.7% | +4.8% | -4.7% | +26.5% | -0.6% | – | |
| – | -1,200.6% | – | -117.1% | – | +214.5% | -202.2% | – | – | – | -221.5% | – | – | |
| – | -2.5% | +126.1% | -88.5% | +46.1% | -39.7% | -61.0% | +55.0% | +6,430.7% | -85.4% | -96.4% | +428.0% | – | |
| – | +219.0% | +21.7% | -42.6% | -35.3% | – | -168.9% | +128.9% | -31.4% | – | -375.6% | +30.7% | – | |
| – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | |
| – | +18,361.3% | -99.9% | +45,544.8% | -107.2% | – | -64.5% | -57.9% | +284.2% | +1,887.7% | -97.9% | +3,209.0% | – | |
| – | – | -110.6% | – | -223.9% | – | +174.2% | -166.1% | – | – | -147.4% | – | – | |
| – | – | – | -1,099.7% | – | – | – | -107.2% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.